# Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers

> **NCT04278391** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWJ1421
- **DRUG:** DWC201903

## Key facts

- **NCT ID:** NCT04278391
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-02
- **Primary completion:** 2019-08-10
- **Final completion:** 2020-02-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04278391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04278391, "Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04278391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*